ResearcherNational and Kapodistrian University of AthensNo recent work listed

Christo Kole

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4695-3723; OpenAlex author ID A5089517830. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. Co-author DOI 10.2147/cmar.s267260 ↗
Immunotherapy for pancreatic cancer: A 2020 update. Co-author DOI 10.1016/j.ctrv.2020.102016 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dimitriοs Schizas · 2 shared papers, 2020–2022 · strength 0.30
- Paper Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. DOI 10.2147/cmar.s267260 ↗
- Paper Immunotherapy for pancreatic cancer: A 2020 update. DOI 10.1016/j.ctrv.2020.102016 ↗
Maximos Frountzas · 1 shared paper, 2022 · strength 0.19
- Paper Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. DOI 10.2147/cmar.s267260 ↗
Evangelos Koustas · 1 shared paper, 2020 · strength 0.11
- Paper Immunotherapy for pancreatic cancer: A 2020 update. DOI 10.1016/j.ctrv.2020.102016 ↗
Michalis V. Karamouzis · 1 shared paper, 2020 · strength 0.11
- Paper Immunotherapy for pancreatic cancer: A 2020 update. DOI 10.1016/j.ctrv.2020.102016 ↗
Dimitrios C. Ziogas · 1 shared paper, 2020 · strength 0.11
- Paper Immunotherapy for pancreatic cancer: A 2020 update. DOI 10.1016/j.ctrv.2020.102016 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.